| PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma MR Migden, D Rischin, CD Schmults, A Guminski, A Hauschild, KD Lewis, ... New England Journal of Medicine 379 (4), 341-351, 2018 | 1269 | 2018 |
| Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing D Rischin, MR Migden, AM Lim, CD Schmults, NI Khushalani, ... Journal for immunotherapy of cancer 8 (1), 2020 | 144 | 2020 |
| Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma BG Modi, J Neustadter, E Binda, J Lewis, RB Filler, SJ Roberts, BY Kwong, ... Science 335 (6064), 104-108, 2012 | 142 | 2012 |
| Cortical deactivation induced by subcortical network dysfunction in limbic seizures DJ Englot, B Modi, AM Mishra, M DeSalvo, F Hyder, H Blumenfeld Journal of Neuroscience 29 (41), 13006-13018, 2009 | 133 | 2009 |
| Ruxolitinib as salvage therapy for chronic graft-versus-host disease B Modi, M Hernandez-Henderson, D Yang, J Klein, S Dadwal, E Kopp, ... Biology of Blood and Marrow Transplantation 25 (2), 265-269, 2019 | 73 | 2019 |
| Characterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patients WM Lin, JM Lewis, RB Filler, BG Modi, KR Carlson, S Reddy, A Thornberg, ... Journal of investigative dermatology 132 (1), 188-197, 2012 | 51 | 2012 |
| Primary cutaneous cryptococcus in a patient with multiple sclerosis treated with fingolimod AK Forrestel, BG Modi, S Longworth, MB Wilck, RG Micheletti JAMA neurology 73 (3), 355-356, 2016 | 42 | 2016 |
| Phase 2 study of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with metastatic cutaneous squamous cell carcinoma (mCSCC; Group 1): 12-month follow-up. AD Guminski, AML Lim, NI Khushalani, CD Schmults, LF Hernandez-Aya, ... Journal of Clinical Oncology 37 (15_suppl), 9526-9526, 2019 | 41 | 2019 |
| Preoperative telephone consultation does not decrease patient anxiety before Mohs micrographic surgery JF Sobanko, D Da Silva, ZCC Fuxench, B Modi, TM Shin, JR Etzkorn, ... Journal of the American Academy of Dermatology 76 (3), 519-526, 2017 | 36 | 2017 |
| Ruxolitinib for the treatment of graft-versus-host disease H Ali, A Salhotra, B Modi, R Nakamura Expert Review of Clinical Immunology 16 (4), 347-359, 2020 | 22 | 2020 |
| Pemetrexed-induced pseudocellulitis reaction with eosinophilic infiltrate on skin biopsy EH Tracey, B Modi, RG Micheletti The American Journal of Dermatopathology 39 (1), e1-e2, 2017 | 17 | 2017 |
| Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma CA Virgen, TA Nguyen, C Di Raimondo, A Amini, KA Margolin, V Parekh, ... JAAD Case Reports 6 (3), 195-197, 2020 | 14 | 2020 |
| 814P Phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 groups 1, 2 and 3 MR Migden, C Schmults, N Khushanlani, A Guminski, AL Chang, K Lewis, ... Annals of Oncology 33, S918-S919, 2022 | 13 | 2022 |
| Vegetative plaques and hemorrhagic pustules R Stavert, CG Bunick, B Modi, DM Robinson, O Ibrahim, E Knopp, ... JAMA dermatology 149 (10), 1231-1232, 2013 | 10 | 2013 |
| The effect of time to postoperative radiation therapy on survival in resected merkel cell carcinoma A Shinde, V Verma, BL Jones, R Li, S Glaser, M Freeman, L Melstrom, ... American Journal of Clinical Oncology 42 (8), 636-642, 2019 | 9 | 2019 |
| Subungual melanoma: A single institution experience CJ LaRocca, L Lai, RA Nelson, B Modi, B Crawford Medical Sciences 9 (3), 57, 2021 | 7 | 2021 |
| BAP1: case report and insight into a novel tumor suppressor K Ghosh, B Modi, WD James, BC Capell BMC dermatology 17, 1-4, 2017 | 7 | 2017 |
| A critical review of belumosudil in adult and pediatric patients with chronic graft-versus-host disease A Salhotra, K Sandhu, J O’Hearn, H Ali, R Nakamura, BG Modi Expert Review of Clinical Immunology 19 (3), 241-251, 2023 | 5 | 2023 |
| Pathologic complete response with radiation and vismodegib in a patient with advanced basal cell carcinoma: A case report A Amini, M Freeman, L Melstrom, KA Margolin, V Parekh, FR Abdulla, ... Molecular and Clinical Oncology 14 (3), 1-1, 2021 | 5 | 2021 |
| Primary Analysis of Phase 2 Results for Cemiplimab, a Human Monoclonal Anti-PD-1, in Patients with Metastatic Cutaneous Squamous Cell Carcinoma D Rischin, MR Migden, ALS Chang SKIN The Journal of Cutaneous Medicine 2, S79-S79, 2018 | 5 | 2018 |
